Ellevest, Inc. Catalyst Biosciences, Inc. Transaction History

Ellevest, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 13, 2021	SELL	$4.1 - $5.33 $16 - $21	-4 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$4.55 - $7.29 $18 - $29	4 New	4 $0

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.